1.Flank ulcer in a patient with primary antiphospholipid syndrome.
Chang Woo LEE ; Moon Hyang PARK
Journal of Korean Medical Science 1999;14(1):110-112
A 32-year-old woman had a recurrent shallow ulcer on the flank. A biopsy specimen showed thromboses in the dermal vessels and she was found to have circulating antiphospholipid antibody with no associated systemic disease. A clean ulcer developed on the flank of a patient with primary antiphospholipid syndrome is considered to be a rarely encountered/unusual presentation of this syndrome.
Adult
;
Antiphospholipid Syndrome/pathology
;
Antiphospholipid Syndrome/complications*
;
Case Report
;
Female
;
Human
;
Skin Ulcer/pathology
;
Skin Ulcer/complications*
2.Antiphospholipid syndrome.
Chinese Journal of Pediatrics 2003;41(2):154-157
Abortion, Habitual
;
complications
;
Antibodies, Antiphospholipid
;
blood
;
Antiphospholipid Syndrome
;
complications
;
pathology
;
therapy
;
Erythema
;
complications
;
Heart Valve Diseases
;
complications
;
Humans
;
Kidney Diseases
;
complications
;
Skin Diseases
;
complications
;
Thrombosis
;
complications
3.Clinical and coronary features of systemic lupus erythematosus patients with coronary artery disease.
Jing YANG ; Dong XU ; Zhu-jun SHEN ; Chong-hui WANG ; Shu-yang ZHANG ; Zhong-jie FAN ; Xiao-feng JIN ; Yong ZENG ; Zhen-yu LIU ; Hong-zhi XIE ; Quan FANG
Chinese Journal of Cardiology 2012;40(5):382-385
OBJECTIVESTo observe the clinical and coronary features of patients with systemic lupus erythematosus (SLE) and coronary artery disease (CAD).
METHODSAmong 2877 SLE inpatients (age ≥ 18 years, male 363, female 2514) admitted in the Peking Union Medical College Hospital between January 1999 to October 2009, 33 patients [mean age (50.7 ± 12.8) years] were diagnosed with CAD and coronary angiogram was available in 20 out of these 33 patients. Clinical and coronary features of these patients were retrospectively reviewed.
RESULTSThe incidence of CAD was significantly higher in male SLE patients than in female patients [2.48% (9/363) vs. 0.95% (24/2514), P = 0.022]. Patients with secondary antiphospholipid syndrome were more likely to suffer from CAD [5.76% (8/139) vs. 0.91% (25/2738), P < 0.001]. Myocardial infarction was the major form of CAD (24/33). Coronary artery angiographic changes included coronary stenosis and occlusions, coronary aneurysms and acute thrombosis and multi-vessel lesions was found in 75.0% (15/20) patients with SLE and CAD.
CONCLUSIONSMale SLE patients and patients with secondary antiphospholipid syndrome are at higher risk for CAD. Myocardial infarction and multi-vessel lesions are common in SLE patients with CAD.
Adolescent ; Adult ; Aged ; Antiphospholipid Syndrome ; complications ; Coronary Angiography ; Coronary Artery Disease ; complications ; pathology ; Female ; Humans ; Lupus Erythematosus, Systemic ; complications ; pathology ; Male ; Middle Aged ; Risk Factors ; Young Adult
4.A Case of Cerebral Infarct in Combined Antiphospholipid Antibody and Ovarian Hyperstimulation Syndrome.
Eun Jung KOO ; Joung Ho RHA ; Byoung Ick LEE ; Myeong Ok KIM ; Choong Kun HA
Journal of Korean Medical Science 2002;17(4):574-576
Ovarian hyperstimulation syndrome is a serious complication of ovulation induction and has a diverse clinical spectrum from edema to thromboembolism. Antiphospholipid antibody syndrome, one of the well known hypercoagulable states, can be also manifested as an arterial or venous thrombosis and recurrent spontaneous abortion. Sometimes a patient with antiphospholipid antibodies might not notice a miscarriage and seek for assisted reproduction treatment, which harbors a chance of developing ovarian hyperstimulation syndrome. If this happens, the ovarian hyperstimulation syndrome can exacerbate the thrombotic complication of underlying antiphospholipid antibody syndrome, resulting in a catastrophic vascular event. The authors experienced a case of middle cerebral artery infarct, which developed during ovarian hyperstimulation syndrome in a 33-yr-old woman with a previous history of fetal loss. An elevated titer of anticardiolipin antibodies was noticed and persisted thereafter. The authors suggest screening tests for the presence of antiphospholipid antibodies before controlled ovarian hyperstimulation.
Adult
;
Antibodies, Anticardiolipin/blood
;
Antiphospholipid Syndrome/*complications/pathology
;
Female
;
Humans
;
Iatrogenic Disease
;
Infarction, Middle Cerebral Artery/*etiology/pathology
;
Magnetic Resonance Angiography
;
Ovarian Hyperstimulation Syndrome/*complications/pathology
;
Ovulation Induction
;
Pregnancy
;
*Pregnancy Complications/pathology
5.Angioedema and systemic lupus erythematosus--a complementary association?
Manjari LAHIRI ; Anita Y N LIM
Annals of the Academy of Medicine, Singapore 2007;36(2):142-145
INTRODUCTIONWe report angioedema as a rare presentation leading to a diagnosis of systemic lupus erythematosus (SLE).
CLINICAL PICTUREA diagnosis of angioedema was delayed in a patient presenting with limb and facial swelling until she developed acute upper airway compromise. After excluding allergic and hereditary angioedema, acquired angioedema (AAE) was suspected, possibly precipitated by respiratory tract infection. Associated clinical and laboratory features led to a diagnosis of SLE.
TREATMENTManagement proved challenging and included high dose steroids and immunosuppressants.
OUTCOMEThe patient responded to treatment and remains in remission without recurrence of the angioedema.
CONCLUSIONAAE occurs due to the acquired deficiency of inhibitor of C1 component of complement (C1 INH). Lymphoproliferative disorders and anti-C1 INH antibodies are well-described associations. However, one should also consider the possibility of SLE.
Angioedema ; blood ; etiology ; physiopathology ; therapy ; Antiphospholipid Syndrome ; diagnosis ; etiology ; Brain ; pathology ; Complement C1 Inactivator Proteins ; analysis ; deficiency ; Female ; Humans ; Lupus Erythematosus, Systemic ; complications ; diagnosis ; etiology ; Magnetic Resonance Imaging ; Middle Aged ; Respiration, Artificial ; Respiratory Insufficiency ; etiology ; therapy